Dr. Michael Yeadon, former Pfizer vice president, warns children are 50 times more likely to be killed by the covid vaccines than the virus itself.

“These covid vaccines are not safe,” he told War Room, Wednesday.

“The gene based design makes your body manufacture virus spike protein, and we know and we’ve known for years that virus spike protein triggers blood clots,” Yeadon explains. “That’s a fundamental problem.”

Dr. Yeadon revealed the astronomically high adverse events from the vaccine alone should have shut them down.

“Here’s the real problem,” he said. “I’m a father and grandfather. Young people are not susceptible to covid-19.

“They’re not at risk,” Dr. Yeadon said. “It’s a crazy thing then to vaccinate them with something that is actually 50 times more likely to kill them than the virus itself.”

“If you look from about January of this year and compare month by month to any previous year…the number is just enormous,” he said. “It’s between 50 and 100 times higher. It’s not my data, it’s the U.S. public data.”

Dr. Yeadon said the VAERS system has reported roughly 5,000 vaccine deaths in the first six months of 2021.

“Normally there’s 200 a year for all vaccines combined,” he said.

“It’s appalling, bluntly,” Dr. Yeadon said. “These should all have been withdrawn.”

Dr. Yeadon also explains how the covid vaccines were “fraudulently” approved — and haven’t even been proven to be effective.

“I’m very pro vaccines,” Yeadon said. “My biggest beef with the vaccines include serious concerns about safety.”

“They have not been sufficiently tested,” he explained. “They were approved for emergency use fraudulently, in my view, because they shouldn’t do it if there are safe and effective medicines. And there are. They have just been hidden.”

Yeadon said hydroxychloroquine, ivermectin, azithromycin, and inhaled steroids are all safe and effective at treating the coronavirus. Each were suppressed by Dr. Fauci, the scientific establishment, and the media.

63 shares
JOIN OUR NEWSLETTER

Don't let big tech silence you, join our newsletter today

Skip to toolbar